Bristol-Myers Squibb Company (BMY)
NYSE · Healthcare
Bristol-Myers Squibb Company Shareholder Equity 2007–2025
Bristol-Myers Squibb Company annual shareholder equity history from 2008 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Bristol-Myers Squibb Company shareholder equity as of December 31, 2025: 18.47B, a 13.09% increase year-over-year.
- Bristol-Myers Squibb Company shareholder equity for 2025 were 18.47B, a 13.09% increase from 2024.
- Bristol-Myers Squibb Company shareholder equity for 2024 were 16.34B, a 44.50% decrease from 2023.
- Bristol-Myers Squibb Company shareholder equity for 2023 were 29.43B, a 5.25% decrease from 2022.
- Bristol-Myers Squibb Company shareholder equity for 2022 were 31.06B.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Bristol-Myers Squibb Company Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $18,473 |
| 2024 | $16,335 |
| 2023 | $29,430 |
| 2022 | $31,061 |
| 2021 | $35,946 |
| 2020 | $37,822 |
| 2019 | $51,598 |
| 2018 | $14,031 |
| 2017 | $11,741 |
| 2016 | $16,177 |
| 2015 | $14,266 |
| 2014 | $14,852 |
| 2013 | $15,154 |
| 2012 | $13,623 |
| 2011 | $15,956 |
Bristol-Myers Squibb Company Shareholder Equity — FAQ
Bristol-Myers Squibb Company (BMY) shareholder equity over the last 19 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BMY's shareholder equity history?
The chart and table above show Bristol-Myers Squibb Company's shareholder equity by year and by quarter, including the growth rate.